We are live on ! Find out more
RVPH

REVIVA PHARMA HLDGS INC
RVPH

Delisted

RVPH was delisted on the 13th of May, 2026.

Back to rankings

3 hedge funds and large institutions have $3.15M invested in REVIVA PHARMA HLDGS INC in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

3% less ownership

Funds ownership: 3.19% → 0.2% (-3%)

77% less funds holding

Funds holding: 13 → 3 (-10)

91% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 11

91% less capital invested

Capital invested by funds: $35.4M → $3.15M (-$32.2M)

Holders
3
Holders Change
-10
Holders Change %
-76.92%
% of All Funds
0.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
1
Reduced
1
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$3.63M
2
UBS Group
UBS Group
Switzerland
+$17.2K

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$8.78M
2
GCL
Glazer Capital LLC
New York
-$7.63M
3
MSU
Mizuho Securities USA
New York
-$5.17M
4
PC
Periscope Capital
Ontario, Canada
-$3.17M
5
YCM
Yakira Capital Management
Connecticut
-$2.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$3.13M +$3.63M +17,915 New
UBS Group
2
UBS Group
Switzerland
$15K +$17.2K +85 +8,500%
TRCT
3
Tower Research Capital (TRC)
New York
$1K -$405 -2 -40%
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
– -$8.78M -40,500 Closed
GCL
5
Glazer Capital LLC
New York
– -$7.63M -35,381 Closed
MSU
6
Mizuho Securities USA
New York
– -$5.17M -24,287 Closed
PC
7
Periscope Capital
Ontario, Canada
– -$3.17M -14,465 Closed
YCM
8
Yakira Capital Management
Connecticut
– -$2.6M -12,084 Closed
WRBC
9
W.R. Berkley Corp
Connecticut
– -$2.04M -9,483 Closed
BCM
10
Basso Capital Management
Connecticut
– -$1.87M -8,704 Closed
Goldman Sachs
11
Goldman Sachs
New York
– -$1.62M -7,500 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
12
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$1.61M -7,500 Closed
Walleye Trading
13
Walleye Trading
New York
– -$640K -2,978 Closed
CAC
14
Cowen and Company
New York
– -$264K -1,230 Closed

RVPH Hedge Fund Activity: Q4 2020 in Review

3 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q4 2020, worth a combined $3.15M — down 91% from $35.4M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of RVPH and 1 opened new positions — a net loss of 10 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $3.63M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $8.78M sold.

  • 3 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q4 2020, down from 13 in Q3 2020.
  • Funds reported $3.15M of REVIVA PHARMA HLDGS INC stock for Q4 2020, down 91% quarter-over-quarter.
  • 1 fund opened new REVIVA PHARMA HLDGS INC positions in Q4 2020 and 11 closed out, a net change of -10 holders.
  • The largest REVIVA PHARMA HLDGS INC buyer in Q4 2020 was Sabby Management, an estimated $3.63M added.
  • The largest REVIVA PHARMA HLDGS INC seller in Q4 2020 was Hudson Bay Capital Management, an estimated $8.78M sold.

Based on aggregated 13F filings for Q4 2020.